Martin F. Dietrich, MD, PhD

Medical Oncologist
The US Oncology Network
Orlando, FL

Authored Items

Promising Efficacy and Manageable Safety of Zongertinib in HER2-Mutant NSCLC: Insights From the Beamion LUNG-1 Trial
By Martin F. Dietrich, MD, PhD
American Association for Cancer Research (AACR)
AACR 2025 - Non–Small Cell Lung Cancer
The Beamion LUNG-1 study explored zongertinib as a promising HER2-targeted therapy for advanced or metastatic non–small cell lung cancer (NSCLC). Read More ›
Efficacy and Safety of Tiragolumab Plus Atezolizumab in PD-L1–High NSCLC: Insights From the SKYSCRAPER-01 Trial
By Martin F. Dietrich, MD, PhD
American Association for Cancer Research (AACR)
AACR 2025 - Non–Small Cell Lung Cancer
SKYSCRAPER-01 evaluated the combination of tiragolumab and atezolizumab and suggests potential antitumor activity in NSCLC. Read More ›


© Amplity, Inc. All Rights Reserved. Privacy Policy